QA: Abbvie Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001551152_2022_Abbvie_Inc.pdf

Logs

Graph

Absolute values for 0001551152, Abbvie Inc

  xvar xval
0 AssetsCurrent 27,928,000,000
1 IntangibleAssetsNetIncludingGoodwill 108,330,000,000
2 PropertyPlantAndEquipmentNet 5,110,000,000
3 remainder_Assets 5,161,000,000
4 LiabilitiesCurrent 35,194,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 17,668,840,956
8 SellingGeneralAndAdministrativeExpense 12,645,598,296
9 ResearchAndDevelopmentExpense 7,973,662,581
10 remainder_Expenses 1,614,971,892
11 remainder_Revenues 61,635,827,465
12 remainder_NetIncome -5,066,433,445
13 remainder_ComprehensiveNetIncome 311,522,476
  yvar yval
0 Assets 146,529,000,000
1 Liabilities 35,194,000,000
2 Expenses 39,903,073,725
3 Revenues 61,635,827,465
4 StockholdersEquity 111,335,000,000
5 NetIncome 16,666,320,295
6 ComprehensiveNetIncome 16,822,081,533
7 BaseVar 144,319,928,556
8 EconomicCapitalRatiobeforeLimitedLiability 2.86
9 EconomicCapitalRatio 3.59

Edgar->Model Mapping

Feature Distribution

Change over Time